annual working capital:
$2.11B+$94.10M(+4.67%)Summary
- As of today (June 22, 2025), ALNY annual working capital is $2.11 billion, with the most recent change of +$94.10 million (+4.67%) on December 31, 2024.
- During the last 3 years, ALNY annual working capital has fallen by -$3.85 million (-0.18%).
- ALNY annual working capital is now -0.18% below its all-time high of $2.11 billion, reached on December 31, 2021.
Performance
ALNY Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$2.19B+$83.62M(+3.96%)Summary
- As of today (June 22, 2025), ALNY quarterly working capital is $2.19 billion, with the most recent change of +$83.62 million (+3.96%) on March 31, 2025.
- Over the past year, ALNY quarterly working capital has increased by +$145.74 million (+7.12%).
- ALNY quarterly working capital is now at all-time high.
Performance
ALNY quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
ALNY Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.7% | +7.1% |
| 3 y3 years | -0.2% | +10.5% |
| 5 y5 years | +54.7% | +76.0% |
ALNY Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +9.6% | at high | +26.4% |
| 5 y | 5-year | -0.2% | +54.7% | at high | +76.0% |
| alltime | all time | -0.2% | >+9999.0% | at high | >+9999.0% |
ALNY Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.19B(+4.0%) |
| Dec 2024 | $2.11B(+4.7%) | $2.11B(-1.2%) |
| Sep 2024 | - | $2.13B(+0.8%) |
| Jun 2024 | - | $2.12B(+3.5%) |
| Mar 2024 | - | $2.05B(+1.6%) |
| Dec 2023 | $2.01B(+4.7%) | $2.01B(-1.0%) |
| Sep 2023 | - | $2.04B(+17.3%) |
| Jun 2023 | - | $1.74B(-7.1%) |
| Mar 2023 | - | $1.87B(-2.9%) |
| Dec 2022 | $1.92B(-8.9%) | $1.92B(+0.3%) |
| Sep 2022 | - | $1.92B(+5.7%) |
| Jun 2022 | - | $1.81B(-8.6%) |
| Mar 2022 | - | $1.98B(-6.1%) |
| Dec 2021 | $2.11B(+4.1%) | $2.11B(+2.3%) |
| Sep 2021 | - | $2.06B(-4.9%) |
| Jun 2021 | - | $2.17B(+47.1%) |
| Mar 2021 | - | $1.48B(-27.3%) |
| Dec 2020 | $2.03B(+48.9%) | $2.03B(+28.9%) |
| Sep 2020 | - | $1.57B(-11.4%) |
| Jun 2020 | - | $1.78B(+42.5%) |
| Mar 2020 | - | $1.25B(-8.6%) |
| Dec 2019 | $1.36B(+33.5%) | $1.36B(-11.7%) |
| Sep 2019 | - | $1.54B(-11.0%) |
| Jun 2019 | - | $1.74B(+39.6%) |
| Mar 2019 | - | $1.24B(+21.7%) |
| Dec 2018 | $1.02B(-37.0%) | $1.02B(-16.3%) |
| Sep 2018 | - | $1.22B(-12.1%) |
| Jun 2018 | - | $1.39B(-11.5%) |
| Mar 2018 | - | $1.57B(-3.1%) |
| Dec 2017 | $1.62B(+200.0%) | $1.62B(+81.6%) |
| Sep 2017 | - | $892.32M(+4.7%) |
| Jun 2017 | - | $851.98M(+69.9%) |
| Mar 2017 | - | $501.40M(-7.2%) |
| Dec 2016 | $540.18M(-48.2%) | $540.18M(-18.9%) |
| Sep 2016 | - | $665.80M(-18.6%) |
| Jun 2016 | - | $817.49M(-16.9%) |
| Mar 2016 | - | $983.71M(-5.7%) |
| Dec 2015 | $1.04B(+60.3%) | $1.04B(+6.0%) |
| Sep 2015 | - | $984.68M(+2.3%) |
| Jun 2015 | - | $962.55M(-4.6%) |
| Mar 2015 | - | $1.01B(+55.1%) |
| Dec 2014 | $651.03M | $651.03M(+11.1%) |
| Sep 2014 | - | $586.17M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $611.38M(+3.6%) |
| Mar 2014 | - | $590.23M(+194.9%) |
| Dec 2013 | $200.16M(+159.2%) | $200.16M(+38.7%) |
| Sep 2013 | - | $144.27M(-10.6%) |
| Jun 2013 | - | $161.29M(-15.3%) |
| Mar 2013 | - | $190.36M(+146.5%) |
| Dec 2012 | $77.21M(+8.7%) | $77.21M(-57.4%) |
| Sep 2012 | - | $181.18M(-1.1%) |
| Jun 2012 | - | $183.28M(+29.2%) |
| Mar 2012 | - | $141.90M(+99.8%) |
| Dec 2011 | $71.04M(-53.3%) | $71.04M(-17.4%) |
| Sep 2011 | - | $86.03M(-30.5%) |
| Jun 2011 | - | $123.80M(-18.2%) |
| Mar 2011 | - | $151.37M(-0.5%) |
| Dec 2010 | $152.09M(-16.8%) | $152.09M(+4.8%) |
| Sep 2010 | - | $145.19M(-15.3%) |
| Jun 2010 | - | $171.48M(-1.9%) |
| Mar 2010 | - | $174.74M(-4.4%) |
| Dec 2009 | $182.80M(-46.8%) | $182.80M(+43.9%) |
| Sep 2009 | - | $127.04M(-27.9%) |
| Jun 2009 | - | $176.09M(-44.1%) |
| Mar 2009 | - | $315.09M(-8.3%) |
| Dec 2008 | $343.67M(+9.3%) | $343.67M(-1.7%) |
| Sep 2008 | - | $349.75M(-21.4%) |
| Jun 2008 | - | $444.90M(+20.1%) |
| Mar 2008 | - | $370.56M(+17.9%) |
| Dec 2007 | $314.43M(+57.3%) | $314.43M(-19.4%) |
| Sep 2007 | - | $390.18M(+123.1%) |
| Jun 2007 | - | $174.85M(-6.2%) |
| Mar 2007 | - | $186.42M(-6.7%) |
| Dec 2006 | $199.86M(+212.6%) | $199.86M(+89.8%) |
| Sep 2006 | - | $105.30M(-2.9%) |
| Jun 2006 | - | $108.46M(-7.4%) |
| Mar 2006 | - | $117.13M(+83.2%) |
| Dec 2005 | $63.93M(+53.7%) | $63.93M(+242.0%) |
| Sep 2005 | - | $18.70M(-24.7%) |
| Jun 2005 | - | $24.82M(-29.7%) |
| Mar 2005 | - | $35.30M(-15.1%) |
| Dec 2004 | $41.61M(+104.5%) | $41.61M(+2.6%) |
| Sep 2004 | - | $40.56M(-3.0%) |
| Jun 2004 | - | $41.81M(+190.5%) |
| Mar 2004 | - | $14.39M(-29.3%) |
| Dec 2003 | $20.34M(+58.4%) | $20.34M |
| Dec 2002 | $12.85M | - |
FAQ
- What is Alnylam Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual working capital year-on-year change?
- What is Alnylam Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
What is Alnylam Pharmaceuticals annual working capital?
The current annual working capital of ALNY is $2.11B
What is the all time high annual working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual working capital is $2.11B
What is Alnylam Pharmaceuticals annual working capital year-on-year change?
Over the past year, ALNY annual working capital has changed by +$94.10M (+4.67%)
What is Alnylam Pharmaceuticals quarterly working capital?
The current quarterly working capital of ALNY is $2.19B
What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly working capital is $2.19B
What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ALNY quarterly working capital has changed by +$145.74M (+7.12%)